Since the start of the pandemic, we have all come a long way. The FDA has granted EUA’s for Moderna, Johnson & Johnson, and Pfizer (for ages 12-15 and ages 5-11). Meanwhile, Pfizer was fully approved for use by the FDA…
FOMAT Medical Research Awarded as “Innovative Company of the Year”
The Oxnard Chamber of Commerce has awarded FOMAT as the Innovative Company of the Year. Oxnard, California, October 5th, 2020 FOMAT Medical Research, is a company focused on the pharmaceutical industry, based in Oxnard, California, and has over 10…
FOMAT Medical Research testing promising antibody cocktail ‘REGN-COV2’ to treat, prevent COVID-19
An antibody cocktail called REGN-COV2 designed to treat and prevent coronavirus infection is being tested at FOMAT Medical Research in Oxnard. FOMAT is launching two clinical trials for COVID-19 treatment, the disease caused by the SARS-COV-2, on Thursday, reported CBS Los…
‘Looking Very Promising’: COVID-19 Prevention, Treatment Clinical Trials Begin In Oxnard
FOMAT Medical Research is testing an antibody cocktail, which has been gaining attention nationally as a possible way to treat and prevent the infection. An important treatment is happening right here in Oxnard California, a Clinical Research Company is working on…
Want to reopen your pharma lab amid COVID-19? Consider these strategies first
COVID-19 has unleashed a logistical conundrum for pharma lab leaders: How do you keep momentum in therapeutics development, when, like all workplaces, most labs have had to either restrict use or close altogether? The answer lies, at least in part, in…
Milken Institute Teams with First Person to Explain the Race to a COVID-19 Vaccine
WASHINGTON–(BUSINESS WIRE)– The Milken Institute, the nonprofit, nonpartisan think tank, and First Person, a San Francisco design and storytelling company, together tell the urgent story of the global race for a COVID-19 vaccine in a newly released interactive experience at: https://www.covid-19vaccinetracker.org/. Developed…
2 Million COVID-19 Cases | ‘Uniquely Worse Than I Can Remember’
With the U.S. surpassing 2 million cases of COVID-19, infectious disease experts have learned a tremendous amount about SARS-CoV-2’s transmissibility, the effects of infection, and how (or how not) to treat it. David Aronoff, MD, of Vanderbilt University Medical Center in…
Biopharma Update on the Novel Coronavirus: June 8
FDA Actions Reissued EUAs: The FDA reissued EUAs revising which types of respirators can be decontaminated for reuse. Availability and Capability of Non-Invasive Monitoring Devices: The FDA issued new guidance that expands the availability and capability of non-invasive monitoring devices. This guidance replaces…
Merck, IAVI Work to Develop COVID-19 Vaccine
Merck (NYSE:MRK) and IAVI announced today that they are collaborating to develop an investigational vaccine against SARS-CoV-2 for preventing COVID-19. The vaccine candidate is slated to use the recombinant vesicular stomatitis virus (rVSV) technology used as the basis for Merck’s Ervebo Ebola Zaire virus…
Phlow Lands $354M Government Contract for COVID-19 Medications
Phlow announced today that it received $354 million in U.S. government funding to manufacture essential medicines at risk of shortage, including those involved in the COVID-19 pandemic response. This Covid-19 medications will be a helping aid to succeed against this terrible…